Benefits and risks of nucleoside analog therapy for hepatitis B. [electronic resource]
Producer: 20090603Description: S112-21 p. digitalISSN:- 1527-3350
No physical items for this record
Publication Type: Consensus Development Conference, NIH; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.